Thomas Zilli

Any wrong or incomplete data? Any missing, misplaced, unlicensed picture? Please report any inaccuracy or lack of information to info@ticinoscienza.ch

1) Prostate cancer radiotherapy and incidental testicular irradiation: Impact on gonadal function

Clinical and Translational Radiation Oncology, 8 marzo 2023

2) Stage III Non-Small-Cell Lung Cancer: An Overview of Treatment Options

Current Oncology, 7 marzo 2023

3) Five fractions of SBRT for prostate cancer

The Lancet Oncology, dicembre 2022

4) Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022

European Urology, 6 dicembre 2022

Facts & figures

Thomas Zilli has coordinated or participated in 4 publications
(as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) whose subjects can be represented by this 19 elements tag cloud:

prostate cancer (3) radiotherapy (2) adjuvant therapy (1) biochemical recurrence (1) hormonal treatment (1) hypogonadism (1) locally advanced prostate cancer (1) lung cancer (1) medical treatment (1) next-generation imaging (1) prostate-specific membrane antigen positron emission tomography imaging (1) salvage radiation therapy (1) salvage therapy (1) sexual toxicity (1) side effects (1) stage III (1) surgery (1) testicles (1) testosterone levels (1)

Thomas Zilli has coordinated or participated in 4 publications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) featured by 4 scientific journals:

Clinical and Translational Radiation Oncology (1) Current Oncology (1) European Urology (1) The Lancet Oncology (1)

Thomas Zilli has coordinated or participated in 4 publications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) involving also 9 co-authors being active in Ticino:

Stefania Rizzo (1) Francersco Martucci (1) Gianfranco Pesce (1) Nicola Fossati (1) Luca Bonomo (1) Filippo Del Grande (1) Davide Giovanni Bosetti (1) Silke Gillessen Sommer (1) Fabio Turco (1)

Thomas Zilli has coordinated or participated in 4 pubblications
(as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) in whose synopsis the 16 most frequently used terms (excluding 27 not relevant terms) are here listed:

T.Z. WORD CLOUD cancer (5) prostate (4) radiotherapy (1) incidental (1) testicular (1) irradiation (1) gonadal (1) fractions (1) non-small-cell (1) lung (1) overview (1) sbrt (1) locally (1) intermediate (1) conference (1) biochemical (1)

In the synopsis of the whole 2666 pubblications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations), the 138 most frequently used terms (excluding 27 not relevant or unfrequently used terms (terms used less than 10 times) are here listed:

THE WHOLE WORD CLOUD cancer (238) covid- (164) thyroid (94) pet (94) cardiac (91) sars-cov- (89) prostate (86) hiv (74) atrial (69) coronary (65) breast (63) pandemic (62) sclerosis (61) lymphoma (60) fibrillation (59) bone (49) aortic (43) artery (42) heart (42) stroke (40) brain (39) carcinoma (35) lung (34) antibodies (34) liver (34) ventricular (32) mri (32) nodules (31) virus (31) metastatic (30) cardiovascular (30) extracellular (30) oncology (29) transcatheter (28) ultrasound (28) myocardial (27) f-fdg (26) tumor (26) dna (26) kidney (24) esmo (23) vesicles (23) mitral (22) hepatitis (22) ehra (21) spinal (21) percutaneous (21) antibody (21) ischemic (21) tuberculosis (21) cervical (20) sperm (19) diabetes (19) implantation (19) ovarian (19) pulmonary (18) infarction (18) knee (18) renal (17) chemotherapy (17) bacterial (17) blood (17) pacing (16) immunodeficiency (16) bladder (16) endovascular (16) vaccination (15) sentinel (15) musculoskeletal (15) antiplatelet (15) transplantation (15) vascular (15) laparoscopic (15) coronavirus (15) urinary (14) tomography (14) transplant (14) mice (14) radiotherapy (14) b-cell (14) tumors (14) neurocognitive (14) implantable (13) leukemia (13) lymph (13) monoclonal (13) vaccine (13) nerve (13) colorectal (13) biomarkers (13) preclinical (13) fdg (13) lymphocytic (12) radiomics (12) fractures (12) arterial (12) metastasis (12) metabolic (12) pneumonia (12) peripheral (12) hemorrhage (12) series (12) biomarker (12) legs (12) esc (12) signaling (11) nuclear (11) adherence (11) fna (11) lockdown (11) male (11) serum (11) hiv- (11) malignancy (11) limb (11) il- (11) metabolism (11) grafts (11) antiretroviral (11) lymphomas (11) dementia (11) membrane (11) tricuspid (10) resonance (10) plasma (10) mutations (10) behavior (10) parkinson (10) baseline (10) experimental (10) osteoarthritis (10) prophylaxis (10) neck (10) arrhythmia (10) contemporary (10) ischemia (10) conference (10) catheter (10)

Thomas Zilli has coordinated or participated in the 4 publications here listed (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations)

1) Prostate cancer radiotherapy and incidental testicular irradiation: Impact on gonadal function

2) Stage III Non-Small-Cell Lung Cancer: An Overview of Treatment Options

3) Five fractions of SBRT for prostate cancer

4) Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022

Thomas Zilli has coordinated or participated in the 4 publications here listed
(as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations)